It is likely that a poor preliminary response to ESA treatment in this population represents a marker for severity of illness. Nevertheless, our ability to predict a poor preliminary response from baseline characteristics was limited, suggesting that the available baseline measures may not completely reflect elements that contribute to a poor initial response. The measure of hemoglobin responsiveness supplied incremental worth in predicting outcome beyond standard baseline measures, suggesting that simple measure itself may have clinical value.Dark, M.D., Adam M. Brufsky, M.D., Ph.D., Susan Y. Chon, M.D., Shannon D. Cox, M.D., E. David Crawford, M.D., James Farrell, M.D. , Edward Giovannucci, M.D., Sc.D., Ernst Lengyel, M.D., Ph.D., Steven K. Libutti, M.D., Patrick D. Maguire, M.D., Atisha Manhas, M.D., Brian J. Kilometers, M.D., F.A.C.S., Christina M. Puchalski, M.D., M.S., F.A.C.P, Fredrika Robertson, Ph.D.,Iris Romero, M.D. Gedge D. Rosson, M.D., Benjamin D Smith, M.D.. AERI merges with AHEADD to support communities influenced by Autism Spectrum Disorder The Autism Education and Research Institute , an organization committed to providing consultative services that incorporates innovative current research in neuro-scientific autism, announces their merging with Achieving in Higher Education with Autism / Developmental Disabilities in order to support consumers, families, schools, and their encircling communities who are impacted by Autism Spectrum Disorders .